| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.006 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |